organization · Reporting owner
REGENTS OF THE UNIVERSITY OF CALIFORNIA
Disclosed activity across 2 companies
Sign in to followReported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (2)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Blue Owl Capital Corp
Report date June 16, 2021 · Filed June 17, 2021
Section 16 reporting ended · disclosed 2021-06-17. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 39,139,093 |
Reported balance
After 2021-06-16 transaction · row 1
1 source rowRow 1 · 2021-06-16 · Sale · Disposed 124,437 · Balance 39,139,093 F1: The price is a weighted average of the multiple trades that took place on 6/16/2021. The lowest price at which the shares were sold was $14.80 and the highest price was $14.97. |
Filing footnotes · ownership attribution and instrument terms
F1: The price is a weighted average of the multiple trades that took place on 6/16/2021. The lowest price at which the shares were sold was $14.80 and the highest price was $14.97.
CONSTELLATION PHARMACEUTICALS INC
Report date November 08, 2019 · Filed November 14, 2019 · Amendment
Section 16 reporting ended · disclosed 2019-11-14. Current position is not established by this disclosure.
Amendment: balances below belong to this corrected disclosure, not necessarily a complete replacement of earlier positions.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 2,197,406 |
Reported balance
After 2019-11-08 transaction · row 1
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 1 · 2019-11-08 · Sale · Disposed 100,000 · Balance 2,197,406 F1: Share amount amended from 100,0000 to 100,000, and Securities Acquired (A) amended to Securities Disposed of (D). |
| Common StockSEC Table I · non-derivative | Direct | 2,123,090 |
Reported balance
After 2019-11-08 transaction · row 2
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 2 · 2019-11-08 · Sale · Disposed 74,316 · Balance 2,123,090 F2: Securities Acquired (A) amended to Securities Disposed of (D), and Amount of Securities Beneficially Owned Following Reported Transaction(s) amended from 2,127,090 to 2,123,090. |
| Common StockSEC Table I · non-derivative | Direct | 2,110,290 |
Reported balance
After 2019-11-12 transaction · row 3
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 3 · 2019-11-12 · Sale · Disposed 12,800 · Balance 2,110,290 F3: Securities Acquired (A) amended to Securities Disposed of (D), and Amount of Securities Beneficially Owned Following Reported Transaction(s) amended from 2,111,290 to 2,110,290. |
Filing footnotes · ownership attribution and instrument terms
F1: Share amount amended from 100,0000 to 100,000, and Securities Acquired (A) amended to Securities Disposed of (D).
F2: Securities Acquired (A) amended to Securities Disposed of (D), and Amount of Securities Beneficially Owned Following Reported Transaction(s) amended from 2,127,090 to 2,123,090.
F3: Securities Acquired (A) amended to Securities Disposed of (D), and Amount of Securities Beneficially Owned Following Reported Transaction(s) amended from 2,111,290 to 2,110,290.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 03, 2020 Filed Jun 4, 2020 01:07 UTC | Blue Owl Capital Corp ORCC · Entity 3829 | SaleCommon Stock | 39,250 | $12.78 | $501,732.75 |
DisclosureSEC source: 0001140361-20-013006 · form4.xml · nonDerivative · entry 2 REGENTS OF THE UNIVERSITY OF CALIFORNIA · CIK 0000315054 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,047,303 F2 · price: The price is a weighted average of the multiple trades that took place on 6/3/2020. The lowest price at which the shares were sold was $12.70 and the highest price was $12.96. Read SEC document |
| June 02, 2020 Filed Jun 4, 2020 01:07 UTC | Blue Owl Capital Corp ORCC · Entity 3829 | SaleCommon Stock | 7,200 | $12.74 | $91,735.20 |
DisclosureSEC source: 0001140361-20-013006 · form4.xml · nonDerivative · entry 1 REGENTS OF THE UNIVERSITY OF CALIFORNIA · CIK 0000315054 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,086,553 F1 · price: The price is a weighted average of the multiple trades that took place on 6/2/2020. The lowest price at which the shares were sold was $12.70 and the highest price was $12.77. Read SEC document |
| May 28, 2020 Filed May 29, 2020 01:02 UTC | Blue Owl Capital Corp ORCC · Entity 3829 | SaleCommon Stock | 120,572 | $12.83 | $1,546,818.19 |
DisclosureSEC source: 0001140361-20-012640 · form4.xml · nonDerivative · entry 2 REGENTS OF THE UNIVERSITY OF CALIFORNIA · CIK 0000315054 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,093,753 F2 · price: The price is a weighted average of the multiple trades that took place on 5/28/2020. The lowest price at which the shares were sold was $12.70 and the highest price was $12.99. Read SEC document |
| May 27, 2020 Filed May 29, 2020 01:02 UTC | Blue Owl Capital Corp ORCC · Entity 3829 | SaleCommon Stock | 35,897 | $12.71 | $456,143.18 |
DisclosureSEC source: 0001140361-20-012640 · form4.xml · nonDerivative · entry 1 REGENTS OF THE UNIVERSITY OF CALIFORNIA · CIK 0000315054 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,214,325 F1 · price: The price is a weighted average of the multiple trades that took place on 5/27/2020. The lowest price at which the shares were sold was $12.70 and the highest price was $12.73. Read SEC document |
| May 21, 2020 Filed May 21, 2020 22:01 UTC | Blue Owl Capital Corp ORCC · Entity 3829 | SaleCommon Stock | 52,742 | $12.66 | $667,871.95 |
DisclosureSEC source: 0001140361-20-012222 · form4.xml · nonDerivative · entry 1 REGENTS OF THE UNIVERSITY OF CALIFORNIA · CIK 0000315054 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,250,222 F1 · price: The price is a weighted average of the multiple trades that took place on 5/21/2020. The lowest price at which the shares were sold was $12.57 and the highest price was $12.71. Read SEC document |
| May 20, 2020 Filed May 21, 2020 00:15 UTC | Blue Owl Capital Corp ORCC · Entity 3829 | SaleCommon Stock | 43,149 | $12.69 | $547,517.66 |
DisclosureSEC source: 0001140361-20-012092 · form4.xml · nonDerivative · entry 1 REGENTS OF THE UNIVERSITY OF CALIFORNIA · CIK 0000315054 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,302,964 F1 · price: The price is a weighted average of the multiple trades that took place on 5/20/2020. The lowest price at which the shares were sold was $12.62 and the highest price was $12.83. Read SEC document |
| May 19, 2020 Filed May 19, 2020 23:33 UTC | Blue Owl Capital Corp ORCC · Entity 3829 | SaleCommon Stock | 49,370 | $12.64 | $624,086.17 |
DisclosureSEC source: 0001140361-20-011982 · form4.xml · nonDerivative · entry 1 REGENTS OF THE UNIVERSITY OF CALIFORNIA · CIK 0000315054 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,346,113 F1 · price: The price is a weighted average of the multiple trades that took place on 5/19/2020. The lowest price at which the shares were sold was $12.54 and the highest price was $12.75. Read SEC document |
| May 11, 2020 Filed May 12, 2020 00:48 UTC | Blue Owl Capital Corp ORCC · Entity 3829 | SaleCommon Stock | 145,000 | $12.58 | $1,823,665.00 |
DisclosureSEC source: 0001140361-20-011342 · form4.xml · nonDerivative · entry 1 REGENTS OF THE UNIVERSITY OF CALIFORNIA · CIK 0000315054 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,395,483 F1 · price: The price is a weighted average of the multiple trades that took place on 5/11/2020. The lowest price at which the shares were sold was $12.50 and the highest price was $12.685. Read SEC document |
| May 08, 2020 Filed May 9, 2020 00:07 UTC | Blue Owl Capital Corp ORCC · Entity 3829 | SaleCommon Stock | 145,000 | $13.06 | $1,894,135.00 |
DisclosureSEC source: 0001140361-20-011168 · form4.xml · nonDerivative · entry 1 REGENTS OF THE UNIVERSITY OF CALIFORNIA · CIK 0000315054 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,540,483 F1 · price: The price is a weighted average of the multiple trades that took place on 5/8/2020. The lowest price at which the shares were sold was $12.61 and the highest price was $13.38. Read SEC document |
| May 07, 2020 Filed May 8, 2020 18:13 UTC | Blue Owl Capital Corp ORCC · Entity 3829 | SaleCommon Stock | 143,000 | $13.15 | $1,880,164.00 |
DisclosureSEC source: 0001140361-20-011069 · form4.xml · nonDerivative · entry 1 REGENTS OF THE UNIVERSITY OF CALIFORNIA · CIK 0000315054 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,685,483 F1 · price: The price is a weighted average of the multiple trades that took place on 5/7/2020. The lowest price at which the shares were sold was $13.00 and the highest price was $13.36. Read SEC document |
| May 05, 2020 Filed May 7, 2020 00:06 UTC | Blue Owl Capital Corp ORCC · Entity 3829 | SaleCommon Stock | 131,878 | $12.61 | $1,662,585.95 |
DisclosureSEC source: 0001140361-20-010882 · form4.xml · nonDerivative · entry 1 REGENTS OF THE UNIVERSITY OF CALIFORNIA · CIK 0000315054 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,828,483 F1 · price: The price is a weighted average of the multiple trades that took place on 5/5/2020. The lowest price at which the shares were sold was $12.50 and the highest price was $12.77. Read SEC document |
| November 12, 2019 Filed Nov 13, 2019 02:19 UTC | CONSTELLATION PHARMACEUTICALS INC CNST · Entity 137050 | SaleCommon Stock | 12,800 | $32.77 | $419,456.00 |
DisclosureSEC source: 0001140361-19-020387 · form4.xml · nonDerivative · entry 3 REGENTS OF THE UNIVERSITY OF CALIFORNIA · CIK 0000315054 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,111,290 Read SEC document |
| November 12, 2019 Filed Nov 14, 2019 01:31 UTC Amendment | CONSTELLATION PHARMACEUTICALS INC CNST · Entity 137050 | SaleCommon Stock | 12,800 | $32.77 | $419,456.00 |
DisclosureSEC source: 0001140361-19-020486 · form4.xml · nonDerivative · entry 3 REGENTS OF THE UNIVERSITY OF CALIFORNIA · CIK 0000315054 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,110,290 F3 · acquired: Securities Acquired (A) amended to Securities Disposed of (D), and Amount of Securities Beneficially Owned Following Reported Transaction(s) amended from 2,111,290 to 2,110,290. F3 · balance_after: Securities Acquired (A) amended to Securities Disposed of (D), and Amount of Securities Beneficially Owned Following Reported Transaction(s) amended from 2,111,290 to 2,110,290. Read SEC document |
| November 08, 2019 Filed Nov 13, 2019 02:19 UTC | CONSTELLATION PHARMACEUTICALS INC CNST · Entity 137050 | SaleCommon Stock | 74,316 | $30.44 | $2,262,179.04 |
DisclosureSEC source: 0001140361-19-020387 · form4.xml · nonDerivative · entry 2 REGENTS OF THE UNIVERSITY OF CALIFORNIA · CIK 0000315054 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,127,090 Read SEC document |
| November 08, 2019 Filed Nov 13, 2019 02:19 UTC | CONSTELLATION PHARMACEUTICALS INC CNST · Entity 137050 | SaleCommon Stock | 1,000,000 | $30.25 | $30,250,000.00 |
DisclosureSEC source: 0001140361-19-020387 · form4.xml · nonDerivative · entry 1 REGENTS OF THE UNIVERSITY OF CALIFORNIA · CIK 0000315054 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,197,406 Read SEC document |
| November 08, 2019 Filed Nov 14, 2019 01:31 UTC Amendment | CONSTELLATION PHARMACEUTICALS INC CNST · Entity 137050 | SaleCommon Stock | 74,316 | $30.44 | $2,262,179.04 |
DisclosureSEC source: 0001140361-19-020486 · form4.xml · nonDerivative · entry 2 REGENTS OF THE UNIVERSITY OF CALIFORNIA · CIK 0000315054 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,123,090 F2 · acquired: Securities Acquired (A) amended to Securities Disposed of (D), and Amount of Securities Beneficially Owned Following Reported Transaction(s) amended from 2,127,090 to 2,123,090. F2 · balance_after: Securities Acquired (A) amended to Securities Disposed of (D), and Amount of Securities Beneficially Owned Following Reported Transaction(s) amended from 2,127,090 to 2,123,090. Read SEC document |
| November 08, 2019 Filed Nov 14, 2019 01:31 UTC Amendment | CONSTELLATION PHARMACEUTICALS INC CNST · Entity 137050 | SaleCommon Stock | 100,000 | $30.25 | $3,025,000.00 |
DisclosureSEC source: 0001140361-19-020486 · form4.xml · nonDerivative · entry 1 REGENTS OF THE UNIVERSITY OF CALIFORNIA · CIK 0000315054 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,197,406 F1 · shares: Share amount amended from 100,0000 to 100,000, and Securities Acquired (A) amended to Securities Disposed of (D). F1 · acquired: Share amount amended from 100,0000 to 100,000, and Securities Acquired (A) amended to Securities Disposed of (D). Read SEC document |
| June 17, 2019 Filed Apr 30, 2020 00:15 UTC | Blue Owl Capital Corp ORCC · Entity 3829 | OtherCommon Stock | 9,463,962.126 | $15.27 | $144,514,701.66 |
DisclosureSEC source: 0001140361-20-010191 · form4.xml · nonDerivative · entry 6 REGENTS OF THE UNIVERSITY OF CALIFORNIA · CIK 0000315054 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,960,361 F1 · kind: Acquisition of shares directly from Issuer as a result of a mandatory capital call. F2 · balance_after: Includes shares automatically acquired pursuant to participation in the Issuer's dividend reinvestment program. Read SEC document |
| March 21, 2019 Filed Apr 30, 2020 00:15 UTC | Blue Owl Capital Corp ORCC · Entity 3829 | OtherCommon Stock | 1,761,102.751 | $15.57 | $27,420,369.83 |
DisclosureSEC source: 0001140361-20-010191 · form4.xml · nonDerivative · entry 5 REGENTS OF THE UNIVERSITY OF CALIFORNIA · CIK 0000315054 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,082,153.509 F1 · kind: Acquisition of shares directly from Issuer as a result of a mandatory capital call. F2 · balance_after: Includes shares automatically acquired pursuant to participation in the Issuer's dividend reinvestment program. Read SEC document |
| February 12, 2019 Filed Apr 30, 2020 00:15 UTC | Blue Owl Capital Corp ORCC · Entity 3829 | OtherCommon Stock | 2,670,815.092 | $15.40 | $41,130,552.42 |
DisclosureSEC source: 0001140361-20-010191 · form4.xml · nonDerivative · entry 4 REGENTS OF THE UNIVERSITY OF CALIFORNIA · CIK 0000315054 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,321,050.758 F1 · kind: Acquisition of shares directly from Issuer as a result of a mandatory capital call. F2 · balance_after: Includes shares automatically acquired pursuant to participation in the Issuer's dividend reinvestment program. Read SEC document |
| December 11, 2018 Filed Apr 30, 2020 00:15 UTC | Blue Owl Capital Corp ORCC · Entity 3829 | OtherCommon Stock | 2,051,655.083 | $15.59 | $31,985,302.74 |
DisclosureSEC source: 0001140361-20-010191 · form4.xml · nonDerivative · entry 3 REGENTS OF THE UNIVERSITY OF CALIFORNIA · CIK 0000315054 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,025,638.193 F1 · kind: Acquisition of shares directly from Issuer as a result of a mandatory capital call. F2 · balance_after: Includes shares automatically acquired pursuant to participation in the Issuer's dividend reinvestment program. Read SEC document |
| October 04, 2018 Filed Apr 30, 2020 00:15 UTC | Blue Owl Capital Corp ORCC · Entity 3829 | OtherCommon Stock | 895,946.698 | $15.30 | $13,707,984.48 |
DisclosureSEC source: 0001140361-20-010191 · form4.xml · nonDerivative · entry 2 REGENTS OF THE UNIVERSITY OF CALIFORNIA · CIK 0000315054 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,399,193.256 F1 · kind: Acquisition of shares directly from Issuer as a result of a mandatory capital call. F2 · balance_after: Includes shares automatically acquired pursuant to participation in the Issuer's dividend reinvestment program. Read SEC document |
| August 20, 2018 Filed Apr 30, 2020 00:15 UTC | Blue Owl Capital Corp ORCC · Entity 3829 | OtherCommon Stock | 1,838,403.42 | $15.46 | $28,421,716.87 |
DisclosureSEC source: 0001140361-20-010191 · form4.xml · nonDerivative · entry 1 REGENTS OF THE UNIVERSITY OF CALIFORNIA · CIK 0000315054 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,503,246.558 F1 · kind: Acquisition of shares directly from Issuer as a result of a mandatory capital call. F2 · balance_after: Includes shares automatically acquired pursuant to participation in the Issuer's dividend reinvestment program. Read SEC document |
| August 06, 2018 Filed Aug 9, 2018 01:23 UTC | Blue Owl Capital Corp NONE · Entity 3829 | PurchaseCommon Stock | 2,533,043.227 | $15.41 | $39,034,196.13 |
DisclosureSEC source: 0001567619-18-000171 · doc1.xml · nonDerivative · entry 1 REGENTS OF THE UNIVERSITY OF CALIFORNIA · CIK 0000315054 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,271,511.912 Read SEC document |
| July 23, 2018 Filed Jul 24, 2018 00:15 UTC | CONSTELLATION PHARMACEUTICALS INC CNST · Entity 137050 | ConversionSeries F Preferred Stock · Derivative | 8,750,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-18-020458 · doc4.xml · derivative · entry 5 REGENTS OF THE UNIVERSITY OF CALIFORNIA · CIK 0000315054 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 794,806 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: On July 23, 2018, the Series E-1 and Series F Preferred Stock converted into Common Stock on a 11.009-for-one basis, and the Series E Preferred Stock converted into Common Stock on a 8.56256-for-one basis, upon the closing of the Issuer's initial public offering without payment of consideration. The Series E, Series E-1 and Series F Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial pubic offering. The shares had no expiration date. F1 · derivative.exercise_date: On July 23, 2018, the Series E-1 and Series F Preferred Stock converted into Common Stock on a 11.009-for-one basis, and the Series E Preferred Stock converted into Common Stock on a 8.56256-for-one basis, upon the closing of the Issuer's initial public offering without payment of consideration. The Series E, Series E-1 and Series F Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial pubic offering. The shares had no expiration date. F1 · derivative.expiration_date: On July 23, 2018, the Series E-1 and Series F Preferred Stock converted into Common Stock on a 11.009-for-one basis, and the Series E Preferred Stock converted into Common Stock on a 8.56256-for-one basis, upon the closing of the Issuer's initial public offering without payment of consideration. The Series E, Series E-1 and Series F Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial pubic offering. The shares had no expiration date. Read SEC document |
| July 23, 2018 Filed Jul 24, 2018 00:15 UTC | CONSTELLATION PHARMACEUTICALS INC CNST · Entity 137050 | ConversionSeries E-1 Preferred Stock · Derivative | 6,502,856 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-18-020458 · doc4.xml · derivative · entry 4 REGENTS OF THE UNIVERSITY OF CALIFORNIA · CIK 0000315054 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 590,684 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: On July 23, 2018, the Series E-1 and Series F Preferred Stock converted into Common Stock on a 11.009-for-one basis, and the Series E Preferred Stock converted into Common Stock on a 8.56256-for-one basis, upon the closing of the Issuer's initial public offering without payment of consideration. The Series E, Series E-1 and Series F Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial pubic offering. The shares had no expiration date. F1 · derivative.exercise_date: On July 23, 2018, the Series E-1 and Series F Preferred Stock converted into Common Stock on a 11.009-for-one basis, and the Series E Preferred Stock converted into Common Stock on a 8.56256-for-one basis, upon the closing of the Issuer's initial public offering without payment of consideration. The Series E, Series E-1 and Series F Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial pubic offering. The shares had no expiration date. F1 · derivative.expiration_date: On July 23, 2018, the Series E-1 and Series F Preferred Stock converted into Common Stock on a 11.009-for-one basis, and the Series E Preferred Stock converted into Common Stock on a 8.56256-for-one basis, upon the closing of the Issuer's initial public offering without payment of consideration. The Series E, Series E-1 and Series F Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial pubic offering. The shares had no expiration date. Read SEC document |
| July 23, 2018 Filed Jul 24, 2018 00:15 UTC | CONSTELLATION PHARMACEUTICALS INC CNST · Entity 137050 | ConversionSeries E Preferred Stock · Derivative | 6,666,666 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-18-020458 · doc4.xml · derivative · entry 3 REGENTS OF THE UNIVERSITY OF CALIFORNIA · CIK 0000315054 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 778,583 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: On July 23, 2018, the Series E-1 and Series F Preferred Stock converted into Common Stock on a 11.009-for-one basis, and the Series E Preferred Stock converted into Common Stock on a 8.56256-for-one basis, upon the closing of the Issuer's initial public offering without payment of consideration. The Series E, Series E-1 and Series F Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial pubic offering. The shares had no expiration date. F1 · derivative.exercise_date: On July 23, 2018, the Series E-1 and Series F Preferred Stock converted into Common Stock on a 11.009-for-one basis, and the Series E Preferred Stock converted into Common Stock on a 8.56256-for-one basis, upon the closing of the Issuer's initial public offering without payment of consideration. The Series E, Series E-1 and Series F Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial pubic offering. The shares had no expiration date. F1 · derivative.expiration_date: On July 23, 2018, the Series E-1 and Series F Preferred Stock converted into Common Stock on a 11.009-for-one basis, and the Series E Preferred Stock converted into Common Stock on a 8.56256-for-one basis, upon the closing of the Issuer's initial public offering without payment of consideration. The Series E, Series E-1 and Series F Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial pubic offering. The shares had no expiration date. Read SEC document |
| July 23, 2018 Filed Jul 24, 2018 00:15 UTC | CONSTELLATION PHARMACEUTICALS INC CNST · Entity 137050 | PurchaseCommon Stock | 133,333 | $15.00 | $1,999,995.00 |
DisclosureSEC source: 0000899243-18-020458 · doc4.xml · nonDerivative · entry 2 REGENTS OF THE UNIVERSITY OF CALIFORNIA · CIK 0000315054 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,297,406 Read SEC document |
| July 23, 2018 Filed Jul 24, 2018 00:15 UTC | CONSTELLATION PHARMACEUTICALS INC CNST · Entity 137050 | ConversionCommon Stock | 2,164,073 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-18-020458 · doc4.xml · nonDerivative · entry 1 REGENTS OF THE UNIVERSITY OF CALIFORNIA · CIK 0000315054 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,164,073 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: On July 23, 2018, the Series E-1 and Series F Preferred Stock converted into Common Stock on a 11.009-for-one basis, and the Series E Preferred Stock converted into Common Stock on a 8.56256-for-one basis, upon the closing of the Issuer's initial public offering without payment of consideration. The Series E, Series E-1 and Series F Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial pubic offering. The shares had no expiration date. Read SEC document |
| June 27, 2018 Filed Jul 2, 2018 20:53 UTC | Blue Owl Capital Corp NONE · Entity 3829 | PurchaseCommon Stock | 2,882,149.88 | $15.50 | $44,673,323.14 |
DisclosureSEC source: 0001140361-18-030928 · doc1.xml · nonDerivative · entry 1 REGENTS OF THE UNIVERSITY OF CALIFORNIA · CIK 0000315054 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,738,468.685 Read SEC document |
| June 09, 2017 Filed Jun 12, 2017 21:10 UTC | Blue Owl Capital Corp NONE · Entity 3829 | PurchaseCommon Stock | 2,603,538.459 | $15.05 | $39,183,253.81 |
DisclosureSEC source: 0001140361-17-024717 · doc1.xml · nonDerivative · entry 1 REGENTS OF THE UNIVERSITY OF CALIFORNIA · CIK 0000315054 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,856,318.805 Read SEC document |
| May 24, 2017 Filed May 30, 2017 20:14 UTC | Blue Owl Capital Corp NONE · Entity 3829 | PurchaseCommon Stock | 1,632,765.346 | $14.97 | $24,442,497.23 |
DisclosureSEC source: 0001140361-17-022815 · doc1.xml · nonDerivative · entry 1 REGENTS OF THE UNIVERSITY OF CALIFORNIA · CIK 0000315054 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,252,780.346 Read SEC document |
| April 17, 2017 Filed Apr 19, 2017 17:42 UTC | Blue Owl Capital Corp NONE · Entity 3829 | PurchaseCommon Stock | 4,500,000 | $15.09 | $67,905,000.00 |
DisclosureSEC source: 0001140361-17-016153 · doc1.xml · nonDerivative · entry 1 REGENTS OF THE UNIVERSITY OF CALIFORNIA · CIK 0000315054 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,620,015 Read SEC document |
| December 27, 2016 Filed Dec 30, 2016 17:19 UTC | Blue Owl Capital Corp NONE · Entity 3829 | PurchaseCommon Stock | 4,301,443 | $14.86 | $63,919,442.98 |
DisclosureSEC source: 0001140361-16-091167 · doc1.xml · nonDerivative · entry 1 REGENTS OF THE UNIVERSITY OF CALIFORNIA · CIK 0000315054 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,120,015 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.